Sorsby's fundus dystrophy. A light and electron microscopic study.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 2482957)

Published in Ophthalmology on December 01, 1989

Authors

M R Capon1, J Marshall, J I Krafft, R A Alexander, P S Hiscott, A C Bird

Author Affiliations

1: Department of Clinical Ophthalmology, Institute of Ophthalmology, London, England.

Articles citing this

Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17

Therapeutic targets in age-related macular disease. J Clin Invest (2010) 1.68

Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol (1993) 1.51

Sorsby fundus dystrophy without a mutation in the TIMP-3 gene. Br J Ophthalmol (2000) 1.48

Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology (2013) 1.43

Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp Eye Res (2011) 1.25

Bruch's membrane change with age. Br J Ophthalmol (1992) 1.19

The genetics of inherited macular dystrophies. J Med Genet (2003) 1.14

Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14

Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol (2008) 1.13

Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol (1997) 1.10

A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy. J Med Genet (1996) 0.95

Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells. Br J Ophthalmol (2002) 0.89

Linkage refinement localises Sorsby fundus dystrophy between markers D22S275 and D22S278. J Med Genet (1995) 0.85

Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up. Br J Ophthalmol (2003) 0.81

Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane. Br J Ophthalmol (2006) 0.80

Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation. Trans Am Ophthalmol Soc (1996) 0.79

Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Mol Vis (2009) 0.78

Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease. Doc Ophthalmol (2001) 0.78

Genetic basis of inherited macular dystrophies and implications for stem cell therapy. Stem Cells (2009) 0.78

A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene. Sci Rep (2016) 0.77

Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase. Trans Am Ophthalmol Soc (2002) 0.76

Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy. J Clin Med (2015) 0.75

The 2014 Bowman Lecture-Bowman's and Bruch's: a tale of two membranes during the laser revolution. Eye (Lond) (2015) 0.75

Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc Natl Acad Sci U S A (2017) 0.75

Biochemical Measurements of Free Opsin in Macular Degeneration Eyes: Examining the 11-CIS Retinal Deficiency Hypothesis of Delayed Dark Adaptation (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2017) 0.75

Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane. Invest Ophthalmol Vis Sci (2017) 0.75

Articles by these authors

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med (1999) 20.31

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

Cerebral blood flow in dementia. Arch Neurol (1975) 9.24

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21

Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature (1992) 8.47

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81

Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet (1974) 3.91

Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell (1991) 3.75

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med (2001) 3.65

Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol (1995) 3.62

A rat brain Na+ channel alpha subunit with novel gating properties. Neuron (1988) 3.48

A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32

Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet (2003) 3.25

X-linked retinitis pigmentosa. Br J Ophthalmol (1975) 3.11

Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (1990) 3.09

Tears of detached retinal pigment epithelium. Br J Ophthalmol (1981) 3.08

A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07

A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97

Visual capacity in the hemianopic field following a restricted occipital ablation. Brain (1974) 2.92

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87

Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82

A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol (1993) 2.77

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61

The mas oncogene encodes an angiotensin receptor. Nature (1988) 2.53

Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymorphism identified by recombinant DNA probe L1.28. Nature (1984) 2.52

Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet (2001) 2.48

Strategies for consulting with the community: the cases of four large-scale genetic databases. Sci Eng Ethics (2004) 2.47

RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections. J Med Genet (2003) 2.45

A comparison of effective thyroxine ratio and free thyroxine in serum. Clin Chim Acta (1973) 2.39

Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron (1990) 2.38

Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34

Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci (1997) 2.31

The reported training and experience of editors in chief of specialist clinical medical journals. JAMA (1998) 2.21

The development of neovascularization of senile disciform macular degeneration. Am J Ophthalmol (1973) 2.17

Diet in the epidemiology of postmenopausal breast cancer in the New York State Cohort. Am J Epidemiol (1992) 2.17

Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K (1986) 2.15

Recent advances in the treatment of senile disciform macular degeneration by photocoagulation. Br J Ophthalmol (1974) 2.14

In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol (1997) 2.10

Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry (1996) 2.09

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain (1981) 2.08

Senile disciform macular degeneration in the second eye. Br J Ophthalmol (1977) 2.07

Bilateral acute retinal necrosis. Br J Ophthalmol (1978) 2.07

The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci (1999) 2.06

Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol (2001) 2.04

An intervention to reduce the sale of cigarettes to minors. N Y State J Med (1990) 2.03

Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology (1990) 1.99

Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol (1980) 1.98

New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med (2001) 1.95

Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med (1999) 1.94

Saccades in presymptomatic and early stages of Huntington disease. Neurology (2006) 1.92

Biochemical and molecular characterization of a novel starch synthase from potato tubers. Plant J (1995) 1.91

Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol (1988) 1.90

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90

Aetiology of Post-arsphenamine Jaundice. Br Med J (1944) 1.89

Multiple organ dysfunction: baseline and serial component scores. Crit Care Med (2001) 1.88

Diurnal variation in occurrence of strokes. Stroke (1977) 1.88

A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa. Am J Hum Genet (1991) 1.88

Photorefractive keratectomy: a technique for laser refractive surgery. J Cataract Refract Surg (1988) 1.88

Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol (1991) 1.87

A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol (1985) 1.87

Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84

Regional blood flow in the normal cerebral hemisphere. J Neurol Neurosurg Psychiatry (1969) 1.84

A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81

Effect of haematocrit on cerebral blood-flow in man. Lancet (1977) 1.80

A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis pigmentosa. Hum Mol Genet (1992) 1.80

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol (2001) 1.80

The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest (1999) 1.80

A mutation in NRL is associated with autosomal dominant retinitis pigmentosa. Nat Genet (1999) 1.79

Messenger RNA coding for only the alpha subunit of the rat brain Na channel is sufficient for expression of functional channels in Xenopus oocytes. Proc Natl Acad Sci U S A (1986) 1.79

Computer assisted tomography in orbital disease. Br J Ophthalmol (1974) 1.79

Cerebral blood-flow in polycythaemia. Lancet (1977) 1.79

Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci (2010) 1.78

A clinical study of the vascularity of senile disciform macular degeneration. Am J Ophthalmol (1973) 1.77

Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75

Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75

Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol (1985) 1.74

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol (2006) 1.74

Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol (2002) 1.74

Immunohistochemical techniques: the effect of melanin bleaching. Br J Biomed Sci (1995) 1.72

Cardiac dysrhythmia and transient cerebral ischaemic attacks. Lancet (1973) 1.71

Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol (1995) 1.71

Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71

Acute zonal occult outer retinopathy: towards a set of diagnostic criteria. Br J Ophthalmol (2005) 1.70

Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol (1985) 1.69

Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci (1992) 1.69

Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol (1990) 1.66

Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66

Drusen as risk factors in age-related macular disease. Am J Ophthalmol (1990) 1.66

Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye (Lond) (1989) 1.66

The natural history of amaurosis fugax. Brain (1968) 1.65

Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol (1980) 1.65

Retinal macroaneurysms. Br J Ophthalmol (1975) 1.64

Model for deriving the optical performance of the myopic eye corrected with an intracorneal ring. J Refract Surg (1996) 1.64

SAP90 binds and clusters kainate receptors causing incomplete desensitization. Neuron (1998) 1.63

Retinopathy in haemoglobin C trait. Eye (Lond) (1996) 1.63

The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62

Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci (1995) 1.61